NCCN Guidelines® Insights - Cervical Cancer Screening
These NCCN Guidelines Insights focus on recent recommendations for cervical cancer screening and management of abnormal screening tests. When the NCCN Panel convened to update the NCCN Guidelines for Cervical Cancer Screening, they decided to adopt and endorse guidelines from other organizations to avoid duplication of effort. Therefore, in July 2013, after review and validation of consensus guidelines from the American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology, the NCCN Guidelines for Cervical Cancer Screening were discontinued.
This activity has been designated to meet the educational needs of physicians, nurses, and pharmacists involved in the management of patients with cancer.
Upon completion of this activity, participants will be able to:
- Inform clinicians of recent changes to cervical cancer screening recommendations and management of abnormal screening test results
- Describe the rationale behind the recent changes in management for cervical cancer screening
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician